Dublin, July 22, 2022 (GLOBE NEWSWIRE) -- The "Hypodermic Needles Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering. The global hypodermic needles market reached a value of US$ 2.48 Billion in 2021. Looking forward, the publisher expects the market to reach a value of US$ 3.86 Billion by 2027 exhibiting a CAGR of 7.20% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor. Hypodermic needles refer to thin, hollow needles used with a syringe to inject substances into the body. They also assist in extracting fluids from the body, such as taking a blood sample from a vein in venipuncture. They are typically manufactured using stainless-steel tubes through the tube drawing process.

Hypodermic needles can also be utilized to provide medications that cannot be ingested orally because they cannot be absorbed easily (like insulin) or potentially harm the patient's liver. Moreover, they have an extremely smooth and sharp surface which prevents and minimizes contamination during inoculation of a sterile substrate. As a result, hypodermic needles find extensive applications in the healthcare sector and research environments requiring sterile conditions. Hypodermic Needles Market Trends:

Hypodermic needles are widely used by medical professionals, physicians, dentists, and paramedics for rapid intradermal delivery of liquids in case of emergencies, vaccination, administration of drugs, and blood sample collection, which represents the primary factor driving the market growth.

Additionally, the widespread prevalence of infections and chronic diseases, such as cancer, diabetes, and cardiovascular disorders, has escalated the demand for vaccines and injectable drugs. Along with this, the ongoing vaccination campaigns to curb the spread of coronavirus disease (COVID-19) across the globe are catalyzing the demand for hypodermic needles. Besides this, the implementation of stringent regulations by governments of various countries that mandate the use of safety needles to prevent needle re-usage and mitigate the risk of infections is propelling the market growth.

Furthermore, several leading manufacturers are developing precision-engineered hypodermic needles to enhance patient comfort in parenteral therapies and reduce penetration resistance. They are also making heavy investments in automated systems for inspection and testing processes to meet the quality standards and ensure the safe administration of medications. Other factors, including the growing need to prevent needle-stick injuries, surging cases of blood-borne diseases, increasing blood donations, improving healthcare infrastructure, and technological advancements, are also creating a favorable market outlook.

The competitive landscape of the industry has also been examined along with the profiles of the key players being B. Braun Melsungen AG, Becton Dickinson and Company, Cardinal Health Inc., Connecticut Hypodermics Inc., EXELINT International Co., Hi-Tech Syringes, McKesson Corporation, Medline Industries LP, Nipro Corporation, Retractable Technologies Inc., Smiths Medical Inc. (ICU Medical Inc.) and Terumo Corporation. Key Questions Answered in This Report:

How has the global hypodermic needles market performed so far and how will it perform in the coming years?

What has been the impact of COVID-19 on the global hypodermic needles market?

What are the key regional markets?

What is the breakup of the market based on the product type?

What is the breakup of the market based on the application?

What is the breakup of the market based on the end user?

What are the various stages in the value chain of the industry?

What are the key driving factors and challenges in the industry?

What is the structure of the global hypodermic needles market and who are the key players?

What is the degree of competition in the industry?

Key Topics Covered: 1 Preface 2 Scope and Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Global Hypodermic Needles Market 5.1 Market Overview 5.2 Market Performance 5.3 Impact of COVID-19 5.4 Market Forecast 6 Market Breakup by Product Type 6.1 Safety Hypodermic Needles 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 Non-Safety Hypodermic Needles 6.2.1 Market Trends 6.2.2 Market Forecast 7 Market Breakup by Application 7.1 Drug Delivery 7.1.1 Market Trends 7.1.2 Market Forecast 7.2 Vaccination 7.2.1 Market Trends 7.2.2 Market Forecast 7.3 Blood Specimen Collection 7.3.1 Market Trends 7.3.2 Market Forecast 8 Market Breakup by End User 8.1 Hospitals and Clinics 8.1.1 Market Trends 8.1.2 Market Forecast 8.2 Ambulatory Surgical Centers 8.2.1 Market Trends 8.2.2 Market Forecast 8.3 Diabetic Patients 8.3.1 Market Trends 8.3.2 Market Forecast 8.4 Family Practices 8.4.1 Market Trends 8.4.2 Market Forecast 8.5 Psychiatrics 8.5.1 Market Trends 8.5.2 Market Forecast 8.6 Others 8.6.1 Market Trends 8.6.2 Market Forecast 9 Market Breakup by Region

10 SWOT Analysis 11 Value Chain Analysis 12 Porters Five Forces Analysis 13 Price Analysis 14 Competitive Landscape 14.1 Market Structure 14.2 Key Players 14.3 Profiles of Key Players 14.3.1 B. Braun Melsungen AG 14.3.1.1 Company Overview 14.3.1.2 Product Portfolio 14.3.1.3 SWOT Analysis 14.3.2 Becton Dickinson and Company 14.3.2.1 Company Overview 14.3.2.2 Product Portfolio 14.3.2.3 Financials 14.3.2.4 SWOT Analysis 14.3.3 Cardinal Health Inc. 14.3.3.1 Company Overview 14.3.3.2 Product Portfolio 14.3.3.3 Financials 14.3.3.4 SWOT Analysis 14.3.4 Connecticut Hypodermics Inc. 14.3.4.1 Company Overview 14.3.4.2 Product Portfolio 14.3.5 EXELINT International Co. 14.3.5.1 Company Overview 14.3.5.2 Product Portfolio 14.3.6 Hi-Tech Syringes 14.3.6.1 Company Overview 14.3.6.2 Product Portfolio 14.3.7 McKesson Corporation 14.3.7.1 Company Overview 14.3.7.2 Product Portfolio 14.3.7.3 Financials 14.3.7.4 SWOT Analysis 14.3.8 Medline Industries LP 14.3.8.1 Company Overview 14.3.8.2 Product Portfolio 14.3.8.3 SWOT Analysis 14.3.9 Nipro Corporation 14.3.9.1 Company Overview 14.3.9.2 Product Portfolio 14.3.9.3 Financials 14.3.9.4 SWOT Analysis 14.3.10 Retractable Technologies Inc. 14.3.10.1 Company Overview 14.3.10.2 Product Portfolio 14.3.10.3 Financials 14.3.11 Smiths Medical Inc. (ICU Medical Inc.) 14.3.11.1 Company Overview 14.3.11.2 Product Portfolio 14.3.11.3 SWOT Analysis 14.3.12 Terumo Corporation 14.3.12.1 Company Overview 14.3.12.2 Product Portfolio 14.3.12.3 Financials 14.3.12.4 SWOT Analysis

For more information about this report visit https://www.researchandmarkets.com/r/yccp3d

Verizon stock is moving lower after an earnings miss and dip in wireless subscriber growth.

When Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) CEO Warren Buffett speaks, Wall Street pays close attention. The easiest way for investors to monitor what Warren Buffett has been buying and selling is to track Berkshire Hathaway's quarterly 13F filings with the Securities and Exchange Commission (SEC).

Snap's 40% stock price crash on Friday after a dismal second quarter earnings report and brutal call is well warranted, one analysts explained to Yahoo Finance.

Cleveland-Cliffs (CLF) delivered earnings and revenue surprises of -2.24% and 4.23%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Yahoo Finance Editor-in-Chief Andy Serwer discusses Berkshire's stake in Occidental Petroleum and what that indicates to investors.

Rivian Automotive (NASDAQ: RIVN) was one of the hottest electric vehicle stocks of 2021. The EV maker went public at $78 per share last November, and its stock started trading at $106.75 before skyrocketing to an all-time high of $172.01 a week later. Rivian initially attracted so much attention because it was backed by Amazon (NASDAQ: AMZN) and Ford (NYSE: F).

Michael Burry, who bet on the collapse of subprime credit, does not hesitate to give his opinion on market developments.

Verizon is set for its worst week since October 2008, but it's sitting on must-hold support right now.

U.S. stocks were under pressure Friday afternoon as a disastrous quarter from Snap weighed on the broader tech sector.

(Bloomberg) -- Verizon Communications Inc. shares plunged to their biggest drop in 14 years after the mobile-phone company cut its forecast for the second straight quarter, adding to concerns that consumers are pulling back on spending.Most Read from BloombergThree Arrows Founders Break Silence Over Collapse of Crypto Hedge FundTrump Insiders Recall How He Spurned Pleas to Act as Riot RagedAmericans Who Can’t Afford Homes Are Moving to Europe InsteadMusk Lieutenant Scrutinized in Internal Tesla

As demand for natural gas around the world soars, the focus in the United States has turned to building the infrastructure for the next stage of the LNG boom

Investors will focus on revenue growth and other pipeline updates, when Tilray (TLRY) reports fiscal fourth-quarter results.

(Bloomberg) -- Volkswagen AG abruptly ousted Herbert Diess, its chief executive officer and architect of the auto industry’s biggest electrification effort, after repeated clashes with labor unions chipped away at his support with key stakeholders.Most Read from BloombergThree Arrows Founders Break Silence Over Collapse of Crypto Hedge FundTrump Insiders Recall How He Spurned Pleas to Act as Riot RagedAmericans Who Can’t Afford Homes Are Moving to Europe InsteadMusk Lieutenant Scrutinized in Int

Yahoo Finance's Brian Cheung and Akiko Fujita discuss Snap earnings and analyst reratings on the stock.

Fed’s zigzagging policies could ultimately lead to an outcome similar to what happened in its fight against inflation four decades ago.

Stock-market bulls are poking their heads above the parapet, but skeptics see little more than a bear-market bounce.

Just where is the stock market going, that’s the question investors are trying to answer. The answer isn’t fully clear, though; markets have fallen for most of this year, but the last few days have seen the best trading in weeks. The problem is, investors and economists aren’t sure if we’re at a true bottom or just in the midst of a bear market rally. What happens next is anyone’s guess, but the history of bears and rallies can offer some suggestions. Looking back to the end of the Second World

The market rally had a strong week despite Friday's losses. Apple leads huge earnings with another big Fed rate hike due.

The energy industry had some of the hottest stocks on the market over the past two years, but with fears of a recession potentially dampening demand for oil and gas, the S&P 500 Energy index is down 25% since its peak last month. The cost of a barrel of oil is down to around $100 per barrel, and gasoline at the pumps has broken from its record high last month of $5 a gallon.

Q.: My wife inherited a 401(k) from my mom who died recently. Assuming this is a traditional 401(k), you are correct that whatever comes out of the account will be likely be taxable to you. Transfer your wife’s share of the money to an Inherited 401(k) with the company that held your mom’s 401(k).